Brind.

BioLife Solutions led an investment round in Pluristyx, a company that has operations in the Seattle area.

1 report, 1 independent Updated Jul 28
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

BioLife Solutions led an investment round in Pluristyx, a company that has operations in the Seattle area.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • Business WirePluristyx Completes Investment Round to Expand Product Portfolio and Commercial Operations SEATTLE, July 28, 2025--(BUSINESS WIRE)--Pluristyx, a leading provider of induced pluripotent stem cell (iPS